Caption Management, LLC Madrigal Pharmaceuticals, Inc. Call Options Transaction History

Caption Management, LLC

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	BUY	$171.37 - $283.23 $3.19 Million - $5.27 Million	18,600 New	18,600 $4.97 Million
Q3 2023 Nov 14, 2023	SELL	$146.04 - $225.78 $5.08 Million - $7.86 Million	-34,800 Reduced 58.0%	25,200 $3.68 Million
Q2 2023 Aug 14, 2023	BUY	$203.88 - $312.0 $12.2 Million - $18.7 Million	60,000 New	60,000 $13.9 Million
Q4 2022 Feb 14, 2023	BUY	$58.39 - $296.54 $1.37 Million - $6.94 Million	23,400 Added 93.6%	48,400 $14 Million
Q3 2022 Nov 14, 2022	BUY	$60.57 - $79.51 $757,125 - $993,875	12,500 Added 100.0%	25,000 $1.63 Million
Q2 2022 Aug 15, 2022	SELL	$58.04 - $100.2 $725,500 - $1.25 Million	-12,500 Reduced 50.0%	12,500 $895,000
Q1 2022 May 13, 2022	BUY	$55.89 - $101.89 $1.4 Million - $2.55 Million	25,000 New	25,000 $2.45 Million
Q1 2021 May 17, 2021	SELL	$108.54 - $125.2 $1.09 Million - $1.25 Million	-10,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$99.78 - $124.21 $997,800 - $1.24 Million	10,000 New	10,000 $1.19 Million
Q3 2019 Nov 14, 2019	SELL	$84.4 - $106.53 $5.48 Million - $6.91 Million	-64,900 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$91.13 - $142.5 $3.27 Million - $5.12 Million	-35,900 Reduced 35.62%	64,900 $6.8 Million
Q4 2018 Jan 30, 2019	BUY	$94.77 - $215.54 $9.55 Million - $21.7 Million	100,800 New	100,800 $11.4 Million

296

22M

819K

640K

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.94B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.